Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Mets Rumors

Joel Hanrahan To Work Out For Teams Next Week

By | at

Free agent closer Joel Hanrahan will host a showcase for teams next week, reports ESPN's Jerry Crasnick (via Twitter). In a second tweet, Crasnick lists the Mets, Yankees, Angels, Rangers, Rockies, Royals, Athletics, Red Sox and Rays as teams that are believed to have interest in Hanrahan. He adds that somewhat curiously, he hasn't heard much buzz on the Tigers or Phillies being interested, though that could always change.

The 32-year-old Hanrahan underwent Tommy John surgery and also had his flexor tendon repaired and bone chips in his elbow removed on May 16 of last season. He opened the year as Boston's closer after being acquired in an offseason trade that sent Mark Melancon to the Pirates, but he allowed eight runs on 10 hits (four homers) and six walks with just five strikeouts in 7 1/3 innings for the Red Sox before landing on the disabled list.

Prior to that season, Hanrahan had averaged 10.2 strikeouts per nine innings over a five-year stretch between the Nationals and Pirates. The Bucs acquired Hanrahan and Lastings Milledge from the Nats in a deal that sent Sean Burnett and Nyjer Morgan to Washington, and Hanrahan blossomed into a two-time All-Star closer with Pittsburgh. Always one of the hardest-throwing pitchers in the game, Hanrahan's 96.5 mph average fastball from his 2011-13 peak ranked seventh in the game among qualified relievers.

Offseason In Review: New York Mets

By | at

As the Mets look to transition from rebuilding to contending, the club made its largest free agent outlay in years, but will go without recovering ace Matt Harvey.

Major League Signings

Notable Minor League Signings
Trades and Claims
Extensions
  • None
Notable Losses

Needs Addressed
 
The Mets addressed their biggest issue, perhaps, by finally saying goodbye to two contracts that turned sour. The club paid its final obligations to both Santana ($5.5MM buyout of $25MM option) and Jason Bay ($3MM buyout on $17MM option). Of course, Bay had already been cut loose, and technically will still be paid for some time due to a deferment arrangement. Likewise, the organization has reportedly made headway in moving past the well-documented financial tribulations of its ownership group.
Granderson
 
The major strategic issue facing Alderson was how to deal with the loss of Harvey, one of the game's best arms, who went down to Tommy John surgery. That constituted a major blow to the team's hopes of beginning to challenge in 2014, and raised the question whether spending would once more be put on hold. But the Mets moved ahead, with Alderson setting down a tall challenge of winning 90 games this year.
 
Having cleared the Santana and Bay contracts, the Mets were able to add the fifth-most in guaranteed money of any team in free agency while opening the season with almost $10MM less on the books than last year. Looking ahead, New York has have the following future obligations: $54.05MM (2015); $45.05MM (2016); and $35.5MM (2017). 
 
So what did GM Sandy Alderson and company get for their cash? First and foremost, it added two veteran outfield options in Granderson and Young. Though the team cobbled together a passable unit last year, they traded away the surprising Marlon Byrd (who would have been a free agent anyway) and was rightly disinclined to rely solely on Juan Lagares, Eric Young Jr., and the defensively-challenged Lucas Duda. An upgrade was clearly in order.
 
In Granderson, the Mets added an established power bat (84 home runs between 2011-12) who missed most of last year due to injury. The cost was high for the qualifying offer-bound 33-year-old: $60MM over four years and the 48th overall choice in the upcoming amateur draft (the team's first choice, tenth overall, was protected). For his part, Young did not require a major commitment, and at age 30 is just a few years removed from a pair of 5-win seasons. But he struggled mightily with injury and performance issues last year. Disappointingly, Young's ongoing quad issues have once again reared up early in the year.
 
The second major area of need that was dealt with by the Mets was pitching. Though blessed with a series of promising young arms — Zach Wheeler cracked the bigs last year, while Noah Syndergaard, Rafael Montero, and others wait in the wings — the organization was at least a year away from fielding its full array of new starters. Absent Harvey, the club plainly had some innings to fill, and did so by adding the seemingly ageless Colon (in fact, he's 40), who threw to a 2.65 ERA in 190 1/3 innings in 2013. Of course, New York would be thrilled by a repeat, but more realistically will hope that Colon can carry that innings load at a slightly above average rate.
 
Alderson filled out the rest of the pitching staff with a series of veterans on minor league deals. Matsuzaka and Lannan provide starting depth, though the former is starting off in Triple-A and the latter in the bullpen. And Valverde and Farnsworth were both added to a bullpen that had a decent number of in-house options, some of whom the organization preferred to start out in the upper minors. 
 
Questions Remaining
 
We already covered two glaring roster needs above, but a third — shortstop — remains a huge question. Ruben Tejada, of course, opens the year as the starter after a massively disappointing 2013 in which he only logged 227 MLB plate appearances and put up a miserly .202/.259/.260 triple-slash. Though Tejada is not regarded as a good defender at the position, advanced metrics have not been quite as down on him as might be expected by the perception. (For his career, at short, Tejada has a slightly positive UZR/150 and is pegged at -8 DRS with over 2,000 innings in the bank.)
 
Though Tejada is just 24 and had been viewed as a promising prospect, it seems that the front office has soured on him quite a bit and has serious questions about his work ethic and conditioning. Moreover, player and team remain at odds — last we heard, anyway — over the decision to recall him just one day after he would have been able to reach three full years of service at the end of the season. Free agent Stephen Drew was a widely-pegged target for New York, but the club seems disinclined to give him the multi-year deal that he seeks. Of course, Drew still remains unsigned, and in theory could still be added, though that seems unlikely unless the Mets improve upon their less-than-inspiring start to the year.
 
Another major question mark that remains unresolved is first base, where Lucas Duda and Ike Davis were expected to battle for the starting role (for this year and, possibly, the future) over the spring. With both sidelined by injuries, that contest never really got started, and both made the Opening Day roster. Duda has been given the first chance to seize hold of the job, with Davis reportedly being shopped. Until a definitive step is taken, that situation remains unclear; even if one or the other is sent packing, moreover, the other will still have much to prove.
 
In the early going, the biggest roster challenge that has arisen is certainly in the bullpen, which has had a rough start to the year. Young power arm Vic Black had been expected to seize a set-up role, but struggled so much in the spring that he was optioned to Triple-A. Then, closer Bobby Parnell suffered a partial tear of the MCL which will require Tommy John surgery. In the immediate term, the question becomes whether Valverde can fill in and whether the rest of the pen can hold things together. Though promotions for younger arms seems to be on the horizon, the Mets must balance their need at the big league level with the desire to keep the focus on an appropriate development timeline for its prospects.
 
Likewise, the starting rotation figures to see its share of flux over the course of the season. Jenrry Mejia got a crack at a role with a solid spring and a need for protection as Jon Niese works his way back, and could stick for the time being. But the 24-year-old has never thrown more than 108 2/3 frames in a professional season, and will certainly face a strict innings limit. Likewise, the pitchers waiting in the wings are not expected to be allowed to carry full starting loads over the entire season. While a late-season return for Harvey remains a theoretical possibility, the club will surely be hesitant to gamble with his future.
 
Deal of Note
 
Granderson unquestionably makes the club better now, but the deal carries some doubt when looked at from other angles. For one thing, the overall commitment is not dissimilar from that given Bay. While the struggles of Bay mean nothing for the outlook of Granderson, that fact illustrates the risk at hand. (Of course, it is fair to think that inflation makes the more recent deal a much-less-significant one in relative terms.) Likewise, the Mets' relatively early strike ended up looking more questionable when the dust finally settled on Nelson Cruz, who ultimately cost just $8MM. While he is a less flexible option, especially for a National League club, and has not matched Granderson's overall production, Cruz required less than 15% the total outlay that the Mets laid out.
 
Of course, the Mets may not have viewed a player like Cruz as a comparable option to Granderson, who the team obviously sees as a valuable long-term piece who fits its expected development arc. "It was what we had to do," said COO Jeff Wilpon. "It was something we wanted to do. It fit well with the plan. And it's a commitment on our part to have him around. He wanted to be around to see the team turn the corner and be a part of it moving forward." Likewise, Alderson cited Granderson's value in impacting the organization's culture. 

"No. 1, he brings a tremendous amount of professionalism," Alderson said. "He brings a personality. He brings credibility. He brings experience. And he brings talent. I think all of those things will be important. I really like the mix of players we have character-wise, personality-wise. I think he will enhance that mix. He's a gregarious, infectious personality."

Ultimately, the deal is not without its risks, but how many free agent contracts are? As Eno Sarris of Fangraphs argued in the aftermath of the signing, Granderson should be a solid-enough defender with a switch to the corner, should be able to stay valuable at the plate, and ultimately may not have received a "glaring overpay." If nothing else, of course, the signing represents the clearest sign that the Mets are ready to supplement their slate of attractive young arms with free agent spending, an important development for an organization that has been in a holding pattern while its owners dealt with the fallout of the Bernie Madoff scandal.

On the other hand, Granderson is already 33, missed much of last year due to wrist injuries, and has seen his strikeout percentage rise quite sharply in recent campaigns. In his limited action last year, Granderson's power dropped back significantly: he landed with a .178 ISO mark, after putting up .290 and .260 marks in 2011 and 2012, respectively. And Granderson, who has never reached base at a consistent clip, is carrying a sub-.320 OBP over the last two seasons. While baseball's inflationary environment means that the deal carries less relative risk than did the Bay contract, it could be that New York is spending a lot of money for a non-impact player who will be well on the decline by the time the team is ready to compete.

Overview

One could say that the team did not make enough of an immediate impact with its free agent signings to warrant the cost. After all, with Harvey out, a jump to playoff contention seems a tall order. But the Opening Day payroll is well shy of last year's tab, and New York can reasonably expect to be better. Given the restlessness of its fans and the organization's hope of building off of a young core to contention in the very near term, it made some sense to put a decent product on the field now while avoiding any truly massive deals that might have stung down the line. The question, of course, is whether that might have been accomplished at a cheaper price, and whether any of the recent commitments will have an impact on future needs.

At present, it is hard to view the Mets' offseason as being fully complete, in large part because major questions (with both short and long-term ramifications) are still open for answers. First base, shortstop, and the back of the bullpen could all see significant moves in the coming months. The true test of Alderson and his staff could well be yet to come, as he navigates the decisions at those spots, manages the team's young arms, and plots the final moves to ready the team for full-on contention.

Photo courtesy of Brad Barr/USA Today Sports Images.

Free Agent Notes: Gimenez, Hanrahan, Available Players

By | at

All remains relatively quiet on the compensation free agent front — as you may have heard, Stephen Drew and Kendrys Morales remain unsigned, though each is now freed of the possibility of receiving another QO next year if they sign a one-year deal. While there have been rumblings that Morales could be approaching a contract, specifics remain unclear. Nevertheless, there is still a good bit of motion among some less-heralded names in the season's early going. Here's the latest:

East Links: Sabathia, Mets, Rays, Roberts

By | at

While much has been made of CC Sabathia's decline over the past year, Mark Feinsand of the New York Daily News writes that it doesn't matter if Sabathia is a true "ace" anymore. Feinsand points to promising starts from Masahiro Tanaka and Michael Pineda in opining that the Yankees can be just fine with Sabathia as a contributor who takes the ball every fifth day. He adds that Sabathia's second start would be perceived a lot differently were it not for one seeing-eye single as well.

Here are some more links pertaining to the game's Eastern divisions…

  • MLB.com's Anthony DiComo tweets that he doesn't get the sense that the Mets are all that interested in Joel Hanrahan, Ryan Madson or any other free agent closers (e.g. Kevin Gregg). Likewise, Matt Ehalt of the North Jersey Record hears from a source that the Mets' plan is to look at internal options for help at this time (Twitter link).
  • Cork Gaines of Rays Index examines the Rays' roster and points out that it's not going to change dramatically over the next few years. While there's a strong likelihood of a David Price trade next offseason, much of the team is controlled through at least the 2016 season. Ben Zobrist and Matt Joyce are exceptions to that rule, but each is controllable through 2015. It's unlikely, Gaines writes, that the Rays will feel pressured to make any big additions next winter, with the possible exception of the bullpen.
  • Both Wil Myers and Jake Odorizzi head to Kansas City to square off against the team that traded them, MLB.com's Dick Kaegel points out. Kaegel, who feels the trade has worked for both clubs despite Shields' impending free agency, spoke with Odorizzi, calls the opportunity to return to Kansas City alongside Myers "special" and says he's looking forward to the experience.
  • In the wake of today's agreement between the Red Sox and Ryan Roberts, ESPN's Buster Olney recalls that multiple scouts told him during Spring Training that the Sox would need to add a third baseman if they weren't planning on promoting Garin Cecchini (Twitter link). Boston added Roberts today after Will Middlebrooks hit the disabled list.

AL Notes: Davis, Kottaras, Omogrosso

By | at

Mets first baseman Ike Davis might make sense for the Yankees, Newsday's Anthony Rieber writes, suggesting that the Yankees could give up a hard-throwing reliever like Dellin Betances for him. While Mark Teixeira is out with a hamstring injury, Davis would be a good replacement for the Yankees since his left-handed power would play well in their ballpark, Rieber argues. Until the Mets deal Davis, Rieber says, they aren't maximizing his value by keeping him on the bench. Here are more notes from the American League.

  • Catcher George Kottaras, who recently agreed to a minor-league deal with the Indians, will make $950K if he's on the big-league roster, Chris Cotillo of MLB Daily Dish tweets. Kottaras can also receive as much as $50K in incentives based on games played. He can opt out of the deal on April 30 if he isn't added to the roster by then. 
  • Brian Omogrosso's agency, MCA, says (via Twitter) that the pitcher is drawing interest from the Yankees, Rangers and Blue Jays after pitching at a showcase Friday in Arizona. The White Sox recently released Omogrosso. He appeared in 37 1/3 innings for them in the past two seasons, posting a 5.54 ERA with 8.2 K/9 and 4.3 BB/9.

Pitcher Notes: Taillon, Parnell

By | at

The Pirates have announced that Jameson Taillon will undergo Tommy John surgery. Taillon's ulnar collateral ligament was "compromised," GM Neal Huntington told reporters, including the Tribune-Review's Karen Price. "As we walked through the process with Jameson, educated him, he's a smart young man and we walked through it with his family and representatives," said Huntington. "He felt this was the best course of action to get back to full health and stay healthy a long time." Taillon, the No. 2 overall pick in the 2010 draft, typically ranked second on lists of the Pirates' top prospects, behind outfielder Gregory Polanco. Taillon had been expected to contribute down the stretch this season, and his absence will take a toll on the Pirates' pitching depth behind starters Gerrit Cole, Francisco Liriano, Charlie Morton, Wandy Rodriguez and Edinson Volquez. Here are more notes on injured pitchers.

  • The Pirates aren't the only team to lose a pitcher to Tommy John. The Mets have announced that Bobby Parnell will undergo the surgery as well. Parnell's surgery will be performed Tuesday. Parnell was among the Mets' top relievers in 2013, posting a 2.16 ERA with 7.9 K/9 and 2.2 BB/9 and serving as their closer for part of the season.
  • If the Mets look outside the organization for relief help, they could turn to Joel Hanrahan, Ryan Madson or Kevin Gregg, Jon Heyman of CBS Sports tweets. Hanrahan and Madson, of course, are coming off injuries of their own — Hanrahan had surgery last May to repair a torn flexor tendon, and Madson has missed the last two seasons with arm trouble.

Mets Still Want To Trade Ike Davis

By | at

The Mets still see dealing first baseman Ike Davis as their "likely endgame," Andy Martino of New York Daily News tweets. They would still like to receive a good return for him, however. Martino had previously reported that the Mets would give Lucas Duda an extended tryout at first base, leaving Davis without a position. Martino writes in a follow-up piece that the Orioles once offered offered Zach Britton for Davis, although that offer is no longer pending.

The Pirates, who tonight will start Travis Ishikawa at first base for the fourth straight game to start the season, remain an obvious potential trade partner if the Mets do decide to trade Davis. Trade rumors surrounding Davis decreased in volume this spring after he spent much of March working through a calf injury. Davis, 27, hit a disappointing .205/.326/.334 in 377 plate appearances for the Mets last season, although he hit .286/.449/.505 in the second half.

Parnell Says 50-50 Chance Of Tommy John Surgery

By | at

THURSDAY: Parnell tells Rubin that team doctors have told him there's a 50-50 chance that he will require Tommy John surgery. Parnell adds that he might not wait the full six weeks described by Alderson yesterday and could have an answer within two weeks. He would like to have the surgery sooner rather than later, if necessary, in order to be ready as early as possible in 2015.

WEDNESDAY: Because the tear occurred in a thicker part of the ligament, Parnell may be able to avoid a Tommy John procedure, GM Sandy Alderson told reporters, including ESPNNewYork.com's Adam Rubin (links to Twitter). Parnell will go through a program to see if he can stay free of surgery, with a final determination in six weeks time. 

In the meantime, Alderson said the club will "continue to monitor" free agent relievers but will wait to see how "things shake out" with his current options before making any moves.

TUESDAY: One day into the season, the Mets are already facing the prospect of an extended absence for their closer, as the team announced that Bobby Parnell has an incomplete tear of the medial collateral ligament in his right elbow (All links to Twitter). Parnell will be shut down completely for two weeks and has already received a platelet-rich plasma injection in the elbow, but surgery is a possible outcome. In the wake of the injury, Andy Martino of the New York Daily News tweets that the Mets "will consider all options," including veteran free agent relievers.

The free agent market contains three names that come with significant experience as a Major League closer; Ryan Madson, Joel Hanrahan and Kevin Gregg are all unsigned, though Madson and Hanrahan are each working their way back from arm injuries (Frank Francisco is also available, but for the time being, I'll assume that ill-fated matchup won't be revisited). As Martino notes in the aforementioned tweet, New York watched Hanrahan throw this winter but didn't elect to send scouts to Madson's showcase.

Joel Sherman of the New York Post tweets that D'Backs right-hander J.J. Putz is "very available" in trades, but he points out that the Mets have already tried that avenue as well in the past (the results were less than spectacular). Sherman hears from scouts that Putz isn't throwing well, and beyond that is the fact that he's set to earn $7MM this season. In a second tweet, he speculates that the Mets won't react by making a big move; the team didn't prioritize the position in the offseason and overvaluing the closer's role isn't GM Sandy Alderson's way, Sherman opines.

For the time being, Jose Valverde will step into the ninth inning for the Mets. After signing a minor league deal this offseason, Valverde had a solid Spring Training and worked 1 1/3 scoreless innings in his first game with the Mets yesterday, including the escape of an inherited bases-loaded jam. The Parnell injury has potentially lucrative ramifications for Valverde, who can reportedly earn up to $1.5MM on top of his $1MM salary based on appearances and games finished (full breakdown here).

Alderson tells Marc Carig of Newsday that a move to the bullpen for Jenrry Mejia isn't an option (Twitter link). Other internal options for the Mets could include Jeurys Familia, Vic Black (though he struggled mightily in Spring Training) and Kyle Farnsworth. For further updates on Parnell and other closer-related news throughout the season, you can follow @closernews on Twitter.

Mets Notes: Duda, Young, Abreu, Bullpen, Colon

By | at

Chris Young's tenure with the Mets isn't off to an ideal start, as the outfielder has already been placed on the disabled list with a quad injury sustained in the cold weather on Wednesday. Young called the situation a "bad dream" when talking with MLB.com's Anthony DiComo, who also spoke to manager Terry Collins about the $7.25MM man's early DL stint. More on the Amazin's as some teams wrap up their opening series…

  • Manager Terry Collins told reporters earlier today that the Mets will give one first baseman a chance to prove himself beginning tomorrow, and Andy Martino of the New York Daily News reports that it will be Lucas Duda, not Ike Davis (Twitter links). Duda will be given a "real shot" to prove he can hold the job down, according to Martino.

Earlier Updates

  • Bobby Abreu's minor league deal with the Mets is worth $800K, and he can opt out if not on the Major League roster by April 30, reports Joel Sherman of the New York Post (via Twitter). Abreu signed with the Mets after his release from the Phillies late last month.
  • The Mets' bullpen woes only increased today, as a variety of arms struggled once again in action against the Nationals. The focal point of that general concern, of course, is injured closer Bobby Parnell, who figures to be out for at least six weeks and possibly much longer. As Ken Davidoff of the New York Post writes, replacing Parnell is a delicate balancing act. An outside addition is always possible, of course, but the options are limited. And while the team may well look to some young arms to bolster the MLB relief corps before long, it will need to be careful not to stunt the development of the team's key prospects.
  • Martino also examined Bartolo Colon's importance to the Mets, and in doing so revealed that the Mets were the only club to offer Colon a multi-year deal. The Mets knew they needed to overpay after five losing seasons, according to Martino, who adds that Tim Hudson was willing to pitch for the Mets earlier in the offseason prior to signing a two-year, $23MM deal with the Giants.

Jeff Todd contributed to this post.

AL East Notes: Archer, Rays, Nunez, Blue Jays

By | at

The Rays officially announced their six-year, $25.5MM extension with Chris Archer in a press conference today.  The right-hander told reporters (including MLB.com's Bill Chastain) that the recent spate of pitching injuries around baseball influenced his decision to sign the contract.  "I don't know if all the injuries — the head injuries, the concussions, the elbow injuries, some shoulder injuries — that have happened of late, I don't know if they've happened as a sign for me, but I took them as a sign for me, a sign of what's unknown," Archer said.  "I sat down with my financial advisor. With this contract, I'm financially secure multiple times over again, through many generations. For me, that's all I ever wanted out of this game — to be personally secure and have my family members secure as well."

Here's some more from around the AL East…

  • Alex Cobb and Wil Myers would seem to be the next logical extension candidates for the Rays, MLB.com's Adam Berry writes.  Cobb said he would "plead the fifth" when asked if he'd been approached by the team about a multiyear deal, while Myers said that he's just focused on playing and will let his agent handle any contractual business.  Berry's piece also contains several quotes from Rays executive VP Andrew Friedman about his team's strategy of locking up its young stars.
  • The Rays have had nine players suspended for PED usage and 14 players suspended for drug-related offenses overall since 2012 , Baseball Prospectus' Ben Lindbergh notes.  Tampa Bay leads all teams in both categories, and the recently-suspended Alex Colome is the only the latest of several of the Rays' top prospects to be hit with a suspension.  Lindbergh, however, believes this current spate of issues is only a matter of "chance," as the franchise doesn't have a glaring suspension record before 2012.
  • The Mets haven't discussed making a move for Eduardo Nunez, Mike Puma of the New York Post tweets, and it's "too early to say if they will have interest" in signing the infielder to bolster their shortstop depth.  The Yankees designated Nunez for assignment yesterday.
  • Blue Jays general manager Alex Anthopoulos told reporters (including Brendan Kennedy of the Toronto Star) that he isn't looking for external shortstop help with Jose Reyes on the DL.  Jonathan Diaz is currently filling in at short, and Anthopoulos doesn't think Reyes' injury will keep him out for too long.
  • ESPN's Jim Bowden (Insider subscription required) doesn't think the Blue Jays will contend this season and the club should deal some top stars in order to restock the farm system.  Edwin Encarnacion headlines Bowden's list of Toronto's ten best trade candidates, which also includes possible trade suitors.
  • In other AL East news, we posted a collection of Red Sox Notes earlier tonight.
Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top